Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
11 03 2022
Historique:
received: 29 01 2022
revised: 15 02 2022
accepted: 16 02 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 27 4 2022
Statut: epublish

Résumé

Lung cancer is one of the most frequent neoplasms in the world. Because it is a complex disease, its formation occurs in several stages, stemming from interactions between environmental risk factors, such as smoking, and individual genetic susceptibility. Our objective was to investigate associations between a

Identifiants

pubmed: 35328047
pii: genes13030493
doi: 10.3390/genes13030493
pmc: PMC8954358
pii:
doi:

Substances chimiques

UGT1A1 enzyme EC 2.4.1.-
Glucuronosyltransferase EC 2.4.1.17

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Genetica. 2016 Jun;144(3):259-65
pubmed: 26984822
J Thorac Dis. 2013 Oct;5 Suppl 5:S454-62
pubmed: 24163739
Cancer Genet. 2012 Apr;205(4):163-7
pubmed: 22559977
Medicine (Baltimore). 2021 Apr 23;100(16):e25478
pubmed: 33879681
Xenobiotica. 2020 Jan;50(1):64-76
pubmed: 31092094
Oncol Lett. 2021 May;21(5):424
pubmed: 33850565
BMC Cancer. 2010 Aug 12;10:422
pubmed: 20704749
Sci Transl Med. 2021 Jan 27;13(578):
pubmed: 33504652
Pharmgenomics Pers Med. 2017 Feb 28;10:61-68
pubmed: 28280378
Eur Respir J. 2015 Mar;45(3):807-27
pubmed: 25657021
NPJ Precis Oncol. 2021 Feb 16;5(1):12
pubmed: 33594163
Oncol Lett. 2012 Jun;3(6):1301-1306
pubmed: 22783438
AIDS Res Hum Retroviruses. 2012 Sep;28(9):1015-8
pubmed: 22050734
Cell. 2021 Apr 15;184(8):1990-2019
pubmed: 33811810
Clin Pharmacol Ther. 2021 Sep;110(3):563-572
pubmed: 34216021
Leuk Res. 2015 Aug 20;:
pubmed: 26321572
Cancer Epidemiol. 2015 Dec;39 Suppl 1:S84-92
pubmed: 26164655
Hum Genomics. 2010 Apr;4(4):238-49
pubmed: 20511137
Front Oncol. 2020 Jul 16;10:1074
pubmed: 32766139
Int J Clin Oncol. 2017 Apr;22(2):269-273
pubmed: 27832386
Eur Respir Rev. 2022 Jan 12;31(163):
pubmed: 35022255
Mutat Res. 2008 Sep 26;644(1-2):56-63
pubmed: 18675828
PLoS One. 2013 Jul 23;8(7):e69367
pubmed: 23935996
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
BMC Cancer. 2010 Aug 30;10:463
pubmed: 20804547
Cancers (Basel). 2021 Mar 29;13(7):
pubmed: 33805415
Mol Diagn Ther. 2014 Dec;18(6):675-83
pubmed: 25312789
BMC Med Genet. 2019 Oct 16;20(1):160
pubmed: 31619193
Clin Chest Med. 2020 Mar;41(1):1-24
pubmed: 32008623
J Natl Compr Canc Netw. 2004 Mar;2(2):125-31
pubmed: 19777702
Contemp Oncol (Pozn). 2021;25(1):45-52
pubmed: 33911981
J Bras Pneumol. 2017 Sep-Oct;43(5):363-367
pubmed: 29160382
Lung Cancer. 2016 Jul;97:66-72
pubmed: 27237030
Sci Rep. 2018 May 9;8(1):7359
pubmed: 29743555
Pharmacogenet Genomics. 2014 Mar;24(3):177-83
pubmed: 24492252
Ann Glob Health. 2019 Jan 22;85(1):
pubmed: 30741509
PLoS One. 2014 Aug 06;9(8):e103972
pubmed: 25100210
J Med Genet. 2021 Apr;58(4):217-226
pubmed: 33514608
PLoS Negl Trop Dis. 2015 Sep 14;9(9):e0004050
pubmed: 26367014
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):94-104
pubmed: 25277794
Salud Publica Mex. 2019 May-Jun;61(3):303-307
pubmed: 31276349
Int J Cancer. 2020 May 1;146(9):2376-2382
pubmed: 31583690
PLoS One. 2021 May 21;16(5):e0252082
pubmed: 34019596
Int J Mol Sci. 2020 Jan 30;21(3):
pubmed: 32019188
Zhongguo Fei Ai Za Zhi. 2017 Dec 20;20(12):817-821
pubmed: 29277179
Sci Rep. 2021 Jul 16;11(1):14572
pubmed: 34272429
Pharmacogenomics. 2008 Jun;9(6):703-15
pubmed: 18518849
World J Gastroenterol. 2017 Dec 28;23(48):8533-8543
pubmed: 29358861
Int J Cancer. 2010 Dec 15;127(12):2815-21
pubmed: 21351260
Mayo Clin Proc. 2019 Aug;94(8):1623-1640
pubmed: 31378236
BMC Public Health. 2017 Feb 14;17(1):191
pubmed: 28193266
Cancers (Basel). 2021 Sep 20;13(18):
pubmed: 34572931
J Antimicrob Chemother. 2020 Aug 1;75(8):2240-2248
pubmed: 32361755
Cancer Res. 2021 May 1;81(9):2566-2573
pubmed: 33653773
Pathol Int. 2010 Nov;60(11):714-9
pubmed: 20946520
J Bras Pneumol. 2018 Jan-Feb;44(1):55-64
pubmed: 29538545
Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):102-9
pubmed: 14744740

Auteurs

Esdras E B Pereira (EEB)

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.

Luciana P C Leitão (LPC)

Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

Roberta B Andrade (RB)

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.

Antônio A C Modesto (AAC)

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.

Bruno M Fernandes (BM)

Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

Rommel M R Burbano (RMR)

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.
Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

Paulo P Assumpção (PP)

Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

Marianne R Fernandes (MR)

Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

João F Guerreiro (JF)

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.

Sidney E B Dos Santos (SEBD)

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.
Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

Ney P C Dos Santos (NPCD)

Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belem 66077-830, Brazil.
Oncology Research Center, Federal University of Pará, Belem 66073-005, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH